GLP-1-based therapies should be used with caution in pregnancy or breastfeeding, and the risk of hypoglycaemia is increased when these agents are used alongside insulin or sulfonylureas
The results of the study were evaluated at two key points: halfway through the trial at 24 weeks and again at the conclusion of the trial at 48 weeks
I'll be back again." Chicago, IL "Loved my experience at Better Med Spa
The findings suggest that the benefits go beyond weight loss, which, in itself, can ease osteoarthritis by reducing pressure on joints
Is it safe for long-term use
Your prescriber will determine whether your primary treatment goal is glycemic control, weight loss, or both, and adjust accordingly